Seeking Alpha

XTLB
  XTL Biopharmaceuticals Ltd. - NASDAQ

8/22/2014, 6:12 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
XTLB vs. ETF Alternatives
Company Description
XTL Biopharmaceuticals, Ltd., is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of MM, schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Sector: Healthcare
Industry: Biotechnology
Country: Israel